US HB3093 | 2023-2024 | 118th Congress
Status
Spectrum: Partisan Bill (Democrat 19-0)
Status: Introduced on May 5 2023 - 25% progression
Action: 2023-05-12 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on May 5 2023 - 25% progression
Action: 2023-05-12 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To require persons who undertake federally funded research and development of a biomedical product or service to enter into reasonable pricing agreements with the Secretary of Health and Human Services, and for other purposes.
Title
Affordable Pricing for Taxpayer-Funded Prescription Drugs Act of 2023
Sponsors
| Rep. Val Hoyle [D-OR] | Rep. Lloyd Doggett [D-TX] | Rep. Steve Cohen [D-TN] | Rep. Rosa DeLauro [D-CT] |
| Rep. Jesus Garcia [D-IL] | Rep. Raul Grijalva [D-AZ] | Rep. Pramila Jayapal [D-WA] | Rep. Marcy Kaptur [D-OH] |
| Rep. Ro Khanna [D-CA] | Rep. Eleanor Norton [D-DC] | Rep. Chellie Pingree [D-ME] | Rep. Mark Pocan [D-WI] |
| Rep. Janice Schakowsky [D-IL] | Rep. Melanie Stansbury [D-NM] | Rep. Jill Tokuda [D-HI] | Rep. Greg Casar [D-TX] |
| Rep. Mark Takano [D-CA] | Rep. Seth Magaziner [D-RI] | Rep. Rashida Tlaib [D-MI] |
History
| Date | Chamber | Action |
|---|---|---|
| 2023-05-12 | House | Referred to the Subcommittee on Health. |
| 2023-05-05 | House | Referred to the House Committee on Energy and Commerce. |
| 2023-05-05 | House | Introduced in House |
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/118th-congress/house-bill/3093/all-info |
| Text | https://www.congress.gov/118/bills/hr3093/BILLS-118hr3093ih.pdf |
